PNPLA3 and steatosis: Several studies have shown that the PNPLA3 I148M variant was also associated with an increased risk of steatosis and fibrosis in liver and kidney, and fat accumulation in this process is causally linked with liver fibrosis and kidney disease progression35,52,53.